In order to revise the guidelines, the Task Force reviewed clinical trials presented at the annual scientific meetings of the ACC, AHA, HRS, and European Society of Cardiology in addition to other peer-reviewed, published data.
These results suggest that CHA2DS2-VASc scores should be continually reassessed, perhaps annually, in patients with atrial fibrillation.
Approximately half of patients with migraine have kinesiophobia, and the condition is associated with greater severity, not presence of cutaneous allodynia.
Investigators examine the long-term outcomes of pallidal deep brain stimulation in x-linked dystonia-parkinsonism.
In patients with Parkinson disease psychosis, treatment with pimavanserin has a lower risk for mortality compared with quetiapine or combination therapy.
The European Headache Federation has issued recommendations on how to best diagnose and treat idiopathic intracranial hypertension.
The novel questionnaire may identify patients with ALS suffering from dyspnea and allow early assessment and monitoring for symptom management.
Lasmiditan was found to be more effective compared with placebo in eliminating pain and other symptoms associated with headache in individuals with migraine.
Investigators examined the involvement of depression and anxiety on cognition and falls in patients with multiple sclerosis.
Investigators sought to determine whether subthalamic nucleus deep brain stimulation could influence clinical outcomes in patients with Parkinson disease.
